Letter to the Editor

You have full text access to this OnlineOpen article

CHEK2*1100delC and male breast cancer risk in Israel

  1. Tal Ohayon1,2,†,
  2. Inbar Gal1,2,†,
  3. Ruth Gershoni Baruch3,4,
  4. Csilla Szabo5,
  5. Eitan Friedman1,2,‡,*

Article first published online: 28 OCT 2003

DOI: 10.1002/ijc.11603

Issue

International Journal of Cancer

International Journal of Cancer

Volume 108, Issue 3, pages 479–480, 20 January 2004

Additional Information

How to Cite

Ohayon, T., Gal, I., Baruch, R. G., Szabo, C. and Friedman, E. (2004), CHEK2*1100delC and male breast cancer risk in Israel. Int. J. Cancer, 108: 479–480. doi: 10.1002/ijc.11603

Author Information

  1. 1

    The Susanne-Levy Gertner Oncogenetics Unit, The Danek Gertner Institute of Genetics, Chaim Sheba Medical Center, Tel-Hashomer, Israel

  2. 2

    The Sackler School of Medicine, Tel-Aviv University, Ramat Aviv, Israel

  3. 3

    Department of Human Genetics, Rambam Medical Center, Haifa, Israel

  4. 4

    The Bruce Rappoport Medical School at the Technion, Haifa, Israel

  5. 5

    Unit of Genetic Epidemiology, International Agency for Research on Cancer, Lyon, France

  1. †

    T. Ohayon and I. Gal contributed equally to this work.

  2. ‡

    Fax: +972-3-535-7308

*The Susanne Levy Gertner Oncogenetics Unit, Chaim Sheba Medical Center, Tel-Hashomer, Israel 52621

Publication History

  1. Issue published online: 21 NOV 2003
  2. Article first published online: 28 OCT 2003
  3. Manuscript Accepted: 28 AUG 2003
  4. Manuscript Received: 18 AUG 2003

Funded by

  • Middle East Cancer Consortium

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (49K)

No abstract is available for this article.

View Full Article (HTML) Get PDF (49K)